Pharmacogenomics — effectively integrated into patients’ everyday clinical care.
The OneOme RightMed® pharmacogenomic test
The OneOme RightMed test is a physician-ordered pharmacogenomic test that analyzes a patient’s DNA to determine how he or she may respond to certain medications. The analysis is provided to the physician in the form of a static and interactive report which clearly identifies which prescription drugs are — or aren’t — likely to work. This information can help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.
How people metabolize drugs
Pharmacogenomics, the study of how an individual's genes affect his or her response to medications, examines metabolization as a major factor contributing to an individual's response to drugs. Knowing how a patient will metabolize, or break down, many drugs will help physicians determine which drugs may work for their patients and reduce the trial-and-error approach.
Depending on variations in a patient’s genes, that patient may break down a drug too slowly or too quickly. If the patient is a poor metabolizer of a given drug, he or she may be exposed to too much of it, which may result in an adverse drug reaction (ADR). If the patient is an ultrarapid metabolizer of a drug, he or she may not get enough to have any effect at all. Since genes don’t change with time, this patient will always be an ultrarapid metabolizer of that drug.
Physicians can use this information to determine optimal drugs and doses for their patients.
Co-developed by Mayo Clinic, the RightMed test is:
Testing for today and tomorrow
OneOme brings clarity and insight into new and existing medications. OneOme’s RightMed PGx test may help with:
Because DNA does not change with time, the OneOme RightMed PGx test may provide years of more accurate decision-making.
OneOme’s RightMed pharmacogenomic test analyzes a patient’s genetic information through our curated clinical PGx knowledgebase to provide information on the individual patient’s PGx profile. The actionable results are delivered to the provider through a variety of decision support tools.